Salient Private Client’s Eli Lilly LLY Stock Holding History

Salient Private Client’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$3.01M	Hold	28,075	–	–	0.59%	47
2018 Q2	$2.4M	Sell	28,075 -6,280	-18%	-$516K	0.4%	68
2018 Q1	$2.66M	Buy	34,355 +6,000	+21%	+$483K	0.47%	64
2017 Q4	$2.4M	Buy	+28,355	New	+$2.41M	0.49%	49

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Salient Private Client's LLY Position: Q3 2018 in Review

Salient Private Client held its Eli Lilly (LLY) position steady in Q3 2018 at 28,075 shares worth $3.01M. The position accounts for 0.59% of the portfolio, ranked #47.

Salient Private Client first reported a position in LLY in Q4 2017 and has held it in 4 quarters since. 1,431 funds tracked by Wall St. Rank hold LLY as of Q3 2018.

Salient Private Client held 28,075 shares of Eli Lilly worth $3.01M as of Q3 2018.
Salient Private Client left its Eli Lilly share count unchanged in Q3 2018.
Eli Lilly made up 0.59% of Salient Private Client's portfolio in Q3 2018, its #47 holding.
Salient Private Client first reported a position in Eli Lilly in Q4 2017 and has held it in 4 quarters since.
1,431 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2018.

Based on Salient Private Client's 13F filing for Q3 2018, filed 14 Nov 2018.